Blackstone Bids On Healthcare, Real Estate Concerns

Jan 25 2007 | 2:21pm ET

Proving that cash is still king, The Blackstone Group this week offered to pay a cool $41 billion to acquire Cardinal Health’s Pharmaceutical Technologies and Services and Equity Office Properties Trust in separate transactions.

Cardinal health is an $81 billion global provider of products and services supporting the healthcare industry, and its PTS businesses develop, manufacture and package medication and other products for pharmaceutical and biotech firms, employing approximately 10,000 at more than 30 facilities worldwide generating approximately $1.8 billion in annual revenue.

Blackstone has agreed to buy PTS for approximately $3.3 billion in cash.
 
“The move allows us to accelerate the repurchase of Cardinal Health shares and focus our full attention on our mission to help make health care safer and more productive through our supply-chain and clinical products businesses,” stated Kerry Clark, president and CEO of Cardinal Healh.

Blackstone is no stranger to the healthcare sector having invested in healthcare concerns such as Biomet, Emcure and Encore Medical.

The firm has also agreed to acquire all of the outstanding common stock of Equity Office Properties Trust for $54 per share, payable in cash, in a transaction valued at approximately $38.3 billion. This offer trumps the $52-a-share cash and stock proposal from a group led by Vornado Realty Trust. Last November, Blackstone made an earlier bid of $48.50 a share for real estate concern.

Equity Office, operating through its various subsidiaries and affiliates, is the largest publicly traded owner and manager of office properties in the United States by square footage, according to the firm.

Equity Office’s board of trustees has unanimously approved and a special meeting of shareholders to vote on the merger agreement remains scheduled to convene on Feb. 5.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR